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Abstract
Purpose: To report amniotic membrane (AM) transplantation in a patient with wound dehiscence
5 months after deep lamellar keratoplasty (DLKP)
Methods: The patient was an 84-year-old Japanese man who had undergone right DLKP 5 months
earlier for central corneal scarring due to recurrent stromal herpetic keratitis. He developed
wound dehiscence with corneal stromal melting due to recurrence of stromal herpes in both the
donor and recipient sites. "AM roll-in filling technique" and AM patching were performed.
Results: Following AM transplantation, stromal inflammation subsided and complete epithelization
occurred within 10 days of surgery.
At 8 months postoperatively, biomicroscopy revealed stable wound apposition or stromal gain.
Following AM transplantation, stromal inflammation subsided and complete epithelialization was
achieved within 10 days after surgery.
Conclusion: AM transplantation may offer an effective treatment modality for herpetic corneal
wound dehiscence after DLKP.
Background
AM transplantation has been reported to be an effective
ocular surface reconstruction procedure in the treatment
of corneal erosions, central or peripheral ulcers and perfo-
rations, as such membranes can decrease inflammation,
promote corneal epithelialization and provide corneal
stromal substrate.[1,2] We report AM transplantation in a
patient with wound dehiscence 5 months after deep
lamellar keratoplasty (DLKP).
Case presentation
An 84-year-old Japanese man was referred to our hospital
for keratoplasty-due to central corneal opacity and periph-
eral corneal neovascularization with lipid deposition in
the right eye (Figure 1A). His medical history showed that
laboratory culture and serological tests had revealed recur-
rent herpetic keratitis in that eye. At his initial visit, the
best corrected visual acuities (BCVA) were 12/200 OD and
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formed (Figure 1, right). Complete graph epithelization
was achieved within 5 days. In addition to 0.1% topical
dexamethasone qid (Sanbethasone®, Santen) and levo-
furoxacine eyedrops qid (Cravit®, Santen) for 5 months,
the patient was prescribed 1000 mg/day oral acyclovir
(Zovirax®, Glaxo Smith Kline), to be commenced the day
prior to the operation and continued for 10 days to pre-
vent herpetic recurrence.
The corneal graft remained in good condition with recov-
ery of BCVA to 20/100 until the fifth postoperative
month, at which time the patient was readmitted with
decreased vision and right ocular pain. Examination
revealed stromal herpetic keratitis, stromal melting and
wound dehiscence with descemetocele at between 2 and 4
o'clock to the donor-recipient apposition site. (Figure 2,
left) The anterior chamber was shallow, and incarceration
of the iris was observed. The patient was prescribed 1000
mg peroral acyclovir and ointment five times a day. Due
to the development of corneal perforation and unavaila-
bility of donor corneal tissue, running sutures were
replaced with interrupted sutures, and frozen AM
trimmed to fit the site was transplanted with a "roll-in fill-
ing technique", i.e., roll-in AM was used to provide
wound apposition without sutures, while a second AM
patch was used to cover the melting area with interrupted
sutures. (Figure2, right, AMT indicated by arrow). Preserv-
ative-free hyaluronate and topical antibiotic eye drops
were prescribed qid. Acyclovir ointment was prescribed
five times a day for 3 months. Following AM transplanta-
tion, stromal inflammation subsided and complete epi-
thelization was achieved within 10 days of surgery. At 8
months postoperatively, biomicroscopy revealed stable
wound apposition and stromal gain.
Discussion
Postkeratoplasty oral acyclovir prophylaxis has been
reported to prevent recurrences. In our opinion, the
wound perforation seen here was a result of insufficient
prophylaxis with recurrence. AM transplantation has been
widely reported to be an efficient procedure for central
and peripheral corneal erosion, ulceration and perfora-
tions. The beneficial effectsof this approach result from
the presence of a rich extracellular matrix and collagen
which provide a stromal substrate as in our case and anti-
inflammatory properties arising from entrapment of
inflammatory cells, the presence of various growth factors,
inhibition of proteinase activity, and decrease of lipid per-
oxidation.[3] AM patch has also been reported to be effec-
tive in acute ulcerative and necrotizing herpetic stromal
keratitis[4] due toreduction of gelatinolytic activity of
MMP-9 and increased expression of TIMP-1.[5] These
properties may have been responsible for the effective
suppression of herpetic inflammation seen in this partic-
ular case.
AM has been commomly used to repair areas of corneal
stromal loss by mutilayered AM, but which technique is
difficult to apply for wound dehiscence because of shape
of stromal loss. Our modified "AM roll-in filling tech-
nique" can provide compact and dense spacer for such
stromal loss site. We have reported the successful applica-
tion of AM in wound dehiscence and herpetic stromal
melting after DLKP. We have also demonstrated the use-
fulness of the "AM roll-in filling technique" for such
patients. Due to availability of corneal donor, this tech-
nique could be used as a first choice in such situation.
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Left, postoperative appearance 5 months after DLKP show-ing ulceration, stromal melting, wound dehiscence and iris carceratiFi r  2
Left, postoperative appearance 5 months after DLKP 
showing ulceration, stromal melting, wound dehis-
cence and iris incarceration. Right, postoperative appear-
ance 2 weeks after AMT.
Left, preoperative appearance showing lipid deposition cov-ering pupilFigure 1
Left, preoperative appearance showing lipid deposi-
tion covering pupil. Right, postoperative appearance 2 
weeks after DLKP. There is blood in the interface between 
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